Making a digital pledge shifted the scale by 1.90 kg

Most people know what a heart-healthy lifestyle looks like; the hard part is doing it, a problem behavioural scientists call the intention-behaviour gap. Lifestyle change is central to preventing cardiovascular disease, yet adherence routinely falls apart once motivation fades. Digital commitment devices borrow from behavioural economics: they get people to bind themselves to a goal in advance so that backing out carries a cost. Whether these tools genuinely move health outcomes in people with cardiometabolic risk factors had never been properly pooled and tested, which is the question this review set out to answer.

The reviewers searched 12 electronic databases from their inception to August 2025, retrieving 7,378 articles. Two reviewers independently selected studies and appraised their quality using Cochrane's risk of bias tool. In the end, 29 randomised controlled trials involving 7,534 adults with elevated cardiometabolic risk made the cut. Where the data allowed, results were pooled statistically, and the certainty of the evidence for each pooled outcome was formally graded.

People using digital commitment devices took an average of 664.87 more steps a day than controls, a finding that was strikingly consistent across trials. They also lost 1.90 kg more weight, although the weight trials disagreed with each other considerably more than the step trials did. Self-reported emotional eating and uncontrolled eating both improved, as did body fat percentage and adherence to diet and medication. What the review could not say is whether any of this lasts, because trials following people beyond 12 months are largely missing.

Commitment devices have a long pedigree in behavioural economics, but their effectiveness for cardiometabolic health had remained unclear until now. This pooling suggests the approach translates into measurable activity and weight changes, not just better intentions. The step-count finding is the most robust because the trials agreed so closely; the weight result deserves a touch more scepticism given how much those trials varied. The authors' own priority for future work is long-term trials that run beyond 12 months to see whether the behaviour, and the physiology, holds.

If you are the sort of person whose plans dissolve by Thursday, this is evidence that structure can substitute for willpower: binding yourself to a goal through an app measurably changed what thousands of people did. The gains are modest rather than dramatic, a few hundred extra steps and under two kilograms of weight, so think of it as a nudge rather than a transformation. It is also unknown whether the effect survives once the novelty wears off. Still, for anyone watching their weight, blood pressure or blood sugar risk, it is a low-cost idea with unusually consistent short-term evidence behind it.